Published in J Bone Metab on May 31, 2014
Paget's disease of bone-genetic and environmental factors. Nat Rev Endocrinol (2015) 0.78
CHMP5 controls bone turnover rates by dampening NF-κB activity in osteoclasts. J Exp Med (2015) 0.78
Recent developments in metabolic bone diseases: a gnathic perspective. Head Neck Pathol (2014) 0.78
Impact of air pollutants on oxidative stress in common autophagy-mediated aging diseases. Int J Environ Res Public Health (2015) 0.77
Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor Cells. PLoS One (2015) 0.75
Paget's disease of bone: an osteoimmunological disorder? Drug Des Devel Ther (2015) 0.75
Intravenous Zoledronate for a Patient with Paget's Disease. J Bone Metab (2014) 0.75
Paget's Disease: Skeletal Manifestations and Effect of Bisphosphonates. J Bone Metab (2017) 0.75
Measles virus nucleocapsid protein modulates the Signal Regulatory Protein-β1 (SIRPβ1) to enhance osteoclast differentiation in Paget's disease of bone. Bone Rep (2016) 0.75
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Triggering the interferon antiviral response through an IKK-related pathway. Science (2003) 11.62
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol (2008) 5.19
Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem (2002) 4.52
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab (2006) 4.33
DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med (2005) 4.02
Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 3.82
Osteoprotection by semaphorin 3A. Nature (2012) 3.40
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet (2002) 3.00
Cytoplasmic PML function in TGF-beta signalling. Nature (2004) 2.89
The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation. EMBO J (1999) 2.80
Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy. Mol Cell (2014) 2.79
The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. Dev Cell (2004) 2.65
NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol (2007) 2.25
Nup93, a vertebrate homologue of yeast Nic96p, forms a complex with a novel 205-kDa protein and is required for correct nuclear pore assembly. Mol Biol Cell (1997) 2.08
RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med (2004) 2.08
Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol (2002) 2.04
Paget disease of bone. J Clin Invest (2005) 1.92
Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med (2010) 1.81
Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. Cell Metab (2011) 1.81
Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet (2002) 1.72
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone (2000) 1.66
Canine distemper virus transcripts sequenced from pagetic bone. Bone Miner (1992) 1.59
Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone. Nat Genet (2010) 1.58
IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem (2006) 1.57
TAK1-dependent signaling requires functional interaction with TAB2/TAB3. J Biol Chem (2006) 1.56
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease. J Clin Invest (2006) 1.52
RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. J Cell Sci (2003) 1.47
Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin. Nat Genet (2008) 1.40
Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res (2002) 1.37
Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype. J Clin Invest (2000) 1.29
The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem (2000) 1.26
Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice. J Bone Miner Res (2005) 1.22
Interleukin-6: an osteotropic factor? J Bone Miner Res (1992) 1.22
Regulation of NF-kappaB action by reversible acetylation. Novartis Found Symp (2004) 1.20
Genome-wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet (2011) 1.20
Sequestosome 1: mutation frequencies, haplotypes, and phenotypes in familial Paget's disease of bone. J Bone Miner Res (2006) 1.19
Bone cell interactions through Eph/ephrin: bone modeling, remodeling and associated diseases. Cell Adh Migr (2012) 1.18
Pathogenesis of Paget disease of bone. Calcif Tissue Int (2012) 1.14
Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop Relat Res (1984) 1.14
Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res (1995) 1.13
A point mutation in the ubiquitin-associated domain of SQSMT1 is sufficient to cause a Paget's disease-like disorder in mice. Hum Mol Genet (2011) 1.12
The regulation of osteoclast function and bone resorption by small GTPases. Small GTPases (2011) 1.11
Osteoclast fusion and regulation by RANKL-dependent and independent factors. World J Orthop (2012) 1.11
Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest (2000) 1.09
Role of TAFII-17, a VDR binding protein, in the increased osteoclast formation in Paget's Disease. J Bone Miner Res (2004) 1.05
SQSTM1 gene analysis and gene-environment interaction in Paget's disease of bone. J Bone Miner Res (2010) 1.04
Toward an integrative view of Optineurin functions. Cell Cycle (2012) 1.04
Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J Biol Chem (1996) 1.01
Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res (2006) 0.99
Optineurin is required for CYLD-dependent inhibition of TNFα-induced NF-κB activation. PLoS One (2011) 0.98
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet (2010) 0.97
Paget's disease of bone: evidence for complex pathogenetic interactions. Semin Arthritis Rheum (2011) 0.96
Paget's disease in New Zealand: evidence for declining prevalence. Bone (2002) 0.96
FGF-2 increases colony formation, PTH receptor, and IGF-1 mRNA in mouse marrow stromal cells. Biochem Biophys Res Commun (2002) 0.93
A functional interaction between ATF7 and TAF12 that is modulated by TAF4. Oncogene (2005) 0.93
Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone. Endocrinology (2011) 0.92
Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int (2004) 0.91
Long-term trends in the incidence of Paget's disease of bone. Bone (2000) 0.91
Detection of canine distemper virus in 100% of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone (1998) 0.90
ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo. J Bone Miner Res (2011) 0.89
Clinical and cellular phenotypes associated with sequestosome 1 (SQSTM1) mutations. J Bone Miner Res (2006) 0.87
Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res (2007) 0.87
Insights into the pathogenesis of Paget's disease. Ann N Y Acad Sci (2010) 0.87
Gene expression profiling in Paget's disease of bone: upregulation of interferon signaling pathways in pagetic monocytes and lymphocytes. J Bone Miner Res (2008) 0.86
Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts. Endocrinology (2001) 0.84
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin. J Bone Miner Res (2004) 0.84
FOXO3 as a new IKK-ε-controlled check-point of regulation of IFN-β expression. Eur J Immunol (2012) 0.84
Is Paget's disease of bone a viral infection? Calcif Tissue Res (1977) 0.83
TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. J Bone Miner Res (2014) 0.83
Involvement of kinase PKC-zeta in the p62/p62(P392L)-driven activation of NF-κB in human osteoclasts. Biochim Biophys Acta (2012) 0.83
Increased IL-6 expression in osteoclasts is necessary but not sufficient for the development of Paget's disease of bone. J Bone Miner Res (2014) 0.83
Paget's disease of bone. Bull N Y Acad Med (1980) 0.83
Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone. J Bone Miner Res (2010) 0.82
Paget's disease of bone: clinical features and treatment. Clin Exp Rheumatol (1985) 0.80
Paramyxoviruses in Paget's disease. Semin Arthritis Rheum (1994) 0.79
The human transcription factor IID subunit human TATA-binding protein-associated factor 28 interacts in a ligand-reversible manner with the vitamin D(3) and thyroid hormone receptors. J Biol Chem (2000) 0.79
Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease. J Bone Miner Res (2013) 0.79
[Structure and ultrastructure of osteoblasts and of the osteoid tissue in Paget's disease of bone (author's transl)]. Pathol Biol (Paris) (1978) 0.78
FGF-2 stimulation of RANK ligand expression in Paget's disease of bone. Mol Endocrinol (2009) 0.78
Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling. Bone (2012) 0.77
SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone. J Cell Biochem (2013) 0.76